Skip to main content
Equibles
NUTX logo

NUTX · Nutex Health Inc. · Metrics

Track NUTX — free

Use NUTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NUTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$200.24 +5.04 (+2.58%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$1.37B
Shares
6.85M

NUTX metrics

87 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$200.24
Market cap
$1.37B

Price action

20 metrics
Price change (1W)
+3.6%
Price change (30D)
+6.8%
Price change (3M)
+38.7%
Price change (6M)
+125.5%
Price change (YTD)
+21.6%
Price change (1Y)
+117.7%
Trailing year
Price change (5Y)
—
52-week high
$200.24
52-week low
$87.01
Change from 52-week high
+0.0%
Change from 52-week low
+130.1%
Annualized volatility
92.3%
Annualized volatility (3M)
78.1%
Beta
2.1
RSI (14D)
61.6
Price vs SMA 50
+13.3%
Price vs SMA 200
+40.4%
Avg volume (3M)
142,912
Relative volume
1.0
Average dollar volume
$25.01M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
6.85M

Valuation

12 metrics
P / E (TTM)
7.7
Trailing earnings · reciprocal yield 13.0%
PEG ratio
0.9
EV / revenue
1.4×
reciprocal yield 70.2%
EV / EBITDA
3.1×
reciprocal yield 32.0%
EV / EBIT
3.3×
reciprocal yield 30.2%
P / sales
1.6×
reciprocal yield 61.7%
P / book
3.5
reciprocal yield 28.8%
FCF yield
20.0%
TTM · current market cap
Buyback yield
4.1%
P / FCF
5.0
reciprocal yield 20.0%
P / operating cash flow
4.9
reciprocal yield 20.4%
Earnings yield
11.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.7×
reciprocal yield 150.6%
EV / revenue historical average (5Y)
8.9×
reciprocal yield 11.2%
EV / EBIT historical average (3Y)
2.4×
reciprocal yield 42.1%
EV / EBIT historical average (5Y)
2.4×
reciprocal yield 42.1%
EV / EBITDA historical average (3Y)
7.8×
reciprocal yield 12.8%
EV / EBITDA historical average (5Y)
7.8×
reciprocal yield 12.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
51.3%
Operating margin
43.0%
Trailing 12 months
Net margin
17.8%
Gross profit (TTM)
$434.03M
Operating profit (TTM)
$364.27M
Net income (TTM)
$150.33M
Trailing 12 months
Diluted EPS (TTM)
$26.00
FCF margin
32.4%
Effective tax rate
20.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$46.49

Growth

11 metrics
Revenue growth YoY
-13.6%
Year over year
Net income growth YoY
+35.9%
Revenue (TTM)
$846.72M
Trailing 12 months
EPS growth YoY
+8.2%
Shares change YoY
+17.1%
Year over year · more shares
Revenue CAGR (3Y)
+58.6%
Revenue CAGR (5Y)
+26.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-17.2%
FCF CAGR (3Y)
+89.7%
FCF CAGR (5Y)
+57.3%

Quality

14 metrics
Return on equity
38.1%
Return on assets
15.6%
Debt / equity
0.1
Current ratio
5.0
EBITDA (TTM)
$385.27M
Free cash flow (TTM)
$274.17M
Quick ratio
5.0
Interest coverage
18.4
Net debt / EBITDA
-0.4
Return on invested capital
126.4%
Trailing 12 months
Net cash
$165.61M
Latest balance sheet
Cash & equivalents
$205.21M
Total assets
$964.63M
Total debt
$39.60M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$279.62M
Capital expenditures (TTM)
$5.45M
R&D (TTM)
$282,910
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
153
13F filer change QoQ
+23
Institutional ownership
42.9%

Short interest

3 metrics
Short interest
17.0%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1479681 CUSIP 67079U306 13F (30d) 46 filings 45 filers Visit website